Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me–Can)

https://doi.org/10.1016/j.ygyno.2012.01.052Get rights and content

Abstract

Background

Little is known about the association between metabolic risk factors and cervical cancer carcinogenesis.

Material and methods

During mean follow-up of 11 years of the Me–Can cohort (N = 288,834) 425 invasive cervical cancer cases were diagnosed. Hazard ratios (HRs) were estimated by the use of Cox proportional hazards regression models for quintiles and standardized z-scores (with a mean of 0 and a SD of 1) of BMI, blood pressure, glucose, cholesterol, triglycerides and MetS score. Risk estimates were corrected for random error in the measurements.

Results

BMI (per 1SD increment) was associated with 12%, increase of cervical cancer risk, blood pressure with 25% and triglycerides with 39%, respectively. In models including all metabolic factors, the associations for blood pressure and triglycerides persisted. The metabolic syndrome (MetS) score was associated with 26% increased corrected risk of cervical cancer. Triglycerides were stronger associated with squamous cell carcinoma (HR 1.48; 95% CI, 1.20–1.83) than with adenocarcinoma (0.92, 0.54–1.56). Among older women cholesterol (50–70 years 1.34; 1.00–1.81), triglycerides (50–70 years 1.49, 1.03–2.16 and ≥ 70 years 1.54, 1.09–2.19) and glucose (≥ 70 years 1.87, 1.13–3.11) were associated with increased cervical cancer risk.

Conclusion

The presence of obesity, elevated blood pressure and triglycerides were associated with increased risk of cervical cancer.

Highlights

► Elevated BMI, blood pressure and triglycerides levels are associated with increased cervical cancer risk. ► A combined score of the MetS is associated with increased cervical cancer risk. ► Associations of metabolic factors differ by histological subtype of cervical cancer.

Introduction

Cervical cancer is the third most frequent cancer in women worldwide and the leading cause for cancer mortality predominantly in women from developing countries [1]. The global burden of obesity and its complications is rising [2], which may also have implication for cancer risk. Most cancers (about 80%) of the uterine cervix are squamous cell carcinoma (SCC). Infections with certain human papillomavirus (HPV) strains 16 and 18 are the major risk factor for cervical cancer [[3], [4]]. More than 150 HPV types have been reported, of which about 40 can infect the cervix [5]. Worldwide the contribution of HPV 16 and 18 was estimated at about 63% of all cervical cancers [[6], [7]]. HPV infections are often acquired in younger age and the persistence of HPV infections is virtually observed in all cervical cancer cases [5]. HPV 18 was more common in ADC than SCC cases and was associated with lower age for women with cervical cancer [6]. Other risk factors include long-term use of oral contraceptives, parity, and smoking [8]. The etiology of ADC may differ from that of SCC [[9], [10]] concerning smoking [11], while both entities share risk factors related to reproductive and sexual behavior [[12], [13], [14]]. Thus, differential association with other factors such as the metabolic syndrome (MetS) can be hypothesized.

The MetS is characterized by obesity, hyperglycemia, dyslipidemia and hypertension and has been shown to increase risk of several common cancer types [15]. Results from previous epidemiological studies have shown associations between some metabolic factors and cervical cancer risk [[10], [16], [17], [18]], for example serum triglyceride levels and systolic blood pressure were positively associated with cervical cancer risk [[17], [18], [19]]. Adipose tissue is an endocrine organ producing hormones and proteins e.g. estrogen and adipokines. Immunological alterations are commonly seen in metabolic disease [20]. For estrogen, adipokine and cytokine associations with cervical cancer have been reported [[21], [22]] suggesting that metabolic factors could play a role as co-factors in the cancerogenesis of cervical cancer. However, little is known about the associations between metabolic factors — individually and combined — and the risk of cervical cancer risk.

The aim of this study was to assess the associations between metabolic factors (both individually and combined) and the risk of cervical cancer by subtype in the large prospective metabolic syndrome and cancer project (Me–Can).

Section snippets

Study population

The Me–Can study design, participating cohorts and data collection procedures have been described in detail previously [[23], [24]]. Briefly, for Me–Can studies data from several long-standing cohorts in Austria (the Vorarlberg Health Monitoring and Prevention Program (VHM&PP)), Norway (the Norwegian Counties Study (NCS), the Cohort of Norway (CONOR) and the Age 40 program (40-y)) and Sweden (the Västerbotten Intervention Project (VIP) and the Malmö Preventive Project (MPP)) were pooled. All

Results

In the Me–Can cohort, mean age at measurement was 44.1 (SD 12.3) years and mean follow-up time was 11.3 (SD 6.8) years (Table 1). Among women with at least one year of follow-up, a total of 425 cases of cervical cancer occurred. Information on histology was available for all cases: 337 (79%) cases with SCC, 59 (14%) cases of ADC, and 29 (7%) cases with other histologic types have been registered. Mean age at diagnosis was 50.5 (SD 11.3) years for all cervical cancer cases combined and 50.5

Discussion

The MetS score was associated with increased risk of cervical cancer in this large, prospective study. Several of the individual MetS components including BMI, blood pressure and triglycerides were significantly associated with increased cervical cancer risk. Triglycerides, blood pressure and the MetS score were stronger confined to SCC than to ADC. Among women with attained age 50 years and older metabolic factors were associated with cervical cancer risk.

In our study, BMI by z-score was

Conclusion

The results of this large prospective study provide the first evidence for an association between cervical cancer and both individual and combined metabolic factors including BMI, blood pressure and triglyceride levels. Different risk patterns of metabolic factors by morphology could be related to difference in the pathogenesis.

Conflict of interest

The authors declared no conflicts of interest.

Funding

This work was supported by the World Cancer Research Fund (Grant 2007/09).

Author contribution

Gabriele Nagel, Hanno Ulmer, Tanja Stocks, Tone Bjørge, Annekatrin Lukanova, Jonas Manjer, Håkan Jonsson, and Pär Stattin were involved in the study conception and design. Tanja Stocks and Pär Stattin were involved in financial support. Administrative support was provided by Tanja Stocks, Christel Häggström, Tone Bjørge, Randi Selmer, Hanno Ulmer, Wegene Borena, Andrea Kleiner, Jonas Manjer, Håkan Jonsson, and Pär Stattin. Study material or patients was provided by Hans Concin, Göran Hallmans.

Acknowledgements

We thank, in Norway, the screening team at the former National Health Screening Service of Norway, now the Norwegian Institute of Public Health, the services of CONOR, and the contributing research centers delivering data to CONOR; in the Vorarlberg Heath Monitoring and Prevention Program, Elmar Stimpfl, data base manager, Karin Parschalk at the cancer registry, and Markus Wallner, Christian Bernhard, Andrea Kaufmann, and Gabriela Dür from the Vorarlberg State Government in the Västerbotten

References (48)

  • I.K. Larsen et al.

    Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness

    Eur J Cancer

    (May 2009)
  • A. Jemal et al.

    Global cancer statistics

    CA Cancer J Clin

    (Feb. 4 2011)
  • S. van Dieren et al.

    The global burden of diabetes and its complications: an emerging pandemic

    Eur J Cardiovasc Prev Rehabil

    (May 2010)
  • J.M. Walboomers et al.

    Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

    J Pathol

    (Sep. 1999)
  • F.X. Bosch et al.

    The causal relation between human papillomavirus and cervical cancer

    J Clin Pathol

    (Apr. 2002)
  • M. Schiffman et al.

    Human papillomavirus testing in the prevention of cervical cancer

    J Natl Cancer Inst

    (Mar. 2 2011)
  • J.S. Smith et al.

    Age-specific prevalence of infection with human papillomavirus in females: a global review

    J Adolesc Health

    (2008 Oct)
  • P. Appleby et al.

    Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies

    Int J Cancer

    (Mar. 15 2006)
  • J.V. Lacey et al.

    Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix

    Cancer

    (Aug. 15 2003)
  • A.S. Kapeu et al.

    Is smoking an independent risk factor for invasive cervical cancer? A nested case–control study within Nordic biobanks

    Am J Epidemiol

    (Feb. 15 2009)
  • A. Berrington de González et al.

    Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis

    Br J Cancer

    (May 4 2004)
  • J. Green et al.

    Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–control Study of Cervical Cancer

    Br J Cancer

    (Dec. 1 2003)
  • F. Parazzini et al.

    Risk factors for adenocarcinoma of the cervix: a case–control study

    Br J Cancer

    (Feb. 1988)
  • H. Ulmer et al.

    Serum triglyceride concentrations and cancer risk in a large cohort study in Austria

    Br J Cancer

    (Oct. 6 2009)
  • Cited by (45)

    • Metabolic syndrome and persistent cervical human papillomavirus infection

      2021, Gynecologic Oncology
      Citation Excerpt :

      The mechanisms leading to persistent infection remain largely unclear [6]. Some researchers have suggested that metabolic syndrome (MetS) or components of metabolic syndrome are risk factors for cervical cancer [7–10]. MetS is defined as having central obesity (defined as waist circumference) plus any two of the following four factors: reduced high density lipoprotein (HDL) cholesterol and elevated cholesterol, blood pressure or fasting plasma glucose [11].

    • The role of adiponectin in obesity-associated female-specific carcinogenesis

      2016, Cytokine and Growth Factor Reviews
      Citation Excerpt :

      The most common cause of cervical cancer is infection with the human papillomavirus (HPV). Recently, however, obesity has been reported to increase the risk of cervical cancer [74–76], mainly of hormonally responsive adenocarcinomas rather than squamous cell carcinomas of the cervix [77]. Another possible factor contributing to the higher cervical cancer incidence in obese women may be that they undergo less frequent screening, such as by Papanicolaou (Pap) smear testing, compared to non-obese women [78–81].

    View all citing articles on Scopus
    View full text